Study Evaluating LAMICTAL Extended-Release Therapy Added To Current Seizure Treatments In Patients With Partial Seizures

PHASE3CompletedINTERVENTIONAL
Enrollment

244

Participants

Timeline

Start Date

October 31, 2004

Primary Completion Date

July 31, 2007

Study Completion Date

July 31, 2007

Conditions
EpilepsyEpilepsy, Partial
Interventions
DRUG

LAMICTAL extended-release

Trial Locations (148)

1181

GSK Investigational Site, Capital Federal

10016

GSK Investigational Site, New York

10117

GSK Investigational Site, Berlin

10969

GSK Investigational Site, Berlin

11803

GSK Investigational Site, Plainview

13353

GSK Investigational Site, Berlin

14974

GSK Investigational Site, Ludwigsfelde

15024

GSK Investigational Site, Cheswick

15601

GSK Investigational Site, Greensburg

16321

GSK Investigational Site, Bernau bei Berlin

19107

GSK Investigational Site, Philadelphia

19140

GSK Investigational Site, Philadelphia

20016

GSK Investigational Site, Washington D.C.

20037

GSK Investigational Site, Washington D.C.

20249

GSK Investigational Site, Hamburg

21029

GSK Investigational Site, Hamburg

22083

GSK Investigational Site, Hamburg

22523

GSK Investigational Site, Hamburg

22527

GSK Investigational Site, Hamburg

23220

GSK Investigational Site, Richmond

23966

GSK Investigational Site, Wismar

23970

GSK Investigational Site, Wismar

24105

GSK Investigational Site, Kiel

27514

GSK Investigational Site, Chapel Hill

27607

GSK Investigational Site, Raleigh

27834

GSK Investigational Site, Greenville

28801

GSK Investigational Site, Asheville

30106

GSK Investigational Site, Austell

30342

GSK Investigational Site, Atlanta

30912

GSK Investigational Site, Augusta

31405

GSK Investigational Site, Savannah

31675

GSK Investigational Site, Bückeburg

32308

GSK Investigational Site, Tallahassee

32751

GSK Investigational Site, Maitland

33021

GSK Investigational Site, Hollywood

33609

GSK Investigational Site, Tampa

34471

GSK Investigational Site, Ocala

35390

GSK Investigational Site, Giessen

35406

GSK Investigational Site, Tuscaloosa

35476

GSK Investigational Site, Northport

36207

GSK Investigational Site, Anniston

37075

GSK Investigational Site, Göttingen

39104

GSK Investigational Site, Magdeburg

39124

GSK Investigational Site, Magdeburg

40202

GSK Investigational Site, Louisville

41017

GSK Investigational Site, Crestview Hills

41061

GSK Investigational Site, Mönchengladbach

44795

GSK Investigational Site, Bochum

44892

GSK Investigational Site, Bochum

45122

GSK Investigational Site, Essen

45138

GSK Investigational Site, Essen

45525

GSK Investigational Site, Hattingen

48149

GSK Investigational Site, Münster

48202

GSK Investigational Site, Detroit

49074

GSK Investigational Site, Osnabrück

49525

GSK Investigational Site, Grand Rapids

49684

GSK Investigational Site, Traverse City

50672

GSK Investigational Site, Cologne

50767

GSK Investigational Site, Cologne

52499

GSK Investigational Site, Baesweiler

53215

GSK Investigational Site, Milwaukee

55422

GSK Investigational Site, Minneapolis

55454

GSK Investigational Site, Minneapolis

60422

GSK Investigational Site, Flossmoor

60594

GSK Investigational Site, Frankfurt am Main

60612

GSK Investigational Site, Chicago

61068

GSK Investigational Site, Kharkiv

61348

GSK Investigational Site, Bad Homburg

62702

GSK Investigational Site, Springfield

63017

GSK Investigational Site, Chesterfield

63110

GSK Investigational Site, St Louis

63755

GSK Investigational Site, Alzenau in Unterfranken

64111

GSK Investigational Site, Kansas City

67117

GSK Investigational Site, Limburgerhof

67214

GSK Investigational Site, Wichita

72205

GSK Investigational Site, Little Rock

73104

GSK Investigational Site, Oklahoma City

73112

GSK Investigational Site, Oklahoma City

75230

GSK Investigational Site, Dallas

75235

GSK Investigational Site, Dallas

76301

GSK Investigational Site, Wichita Falls

77005

GSK Investigational Site, Houston

77555

GSK Investigational Site, Galveston

78224

GSK Investigational Site, Singen

78258

GSK Investigational Site, San Antonio

79021

GSK Investigational Site, Lviv

80331

GSK Investigational Site, Munich

82008

GSK Investigational Site, Unterhaching

84107

GSK Investigational Site, Salt Lake City

84524

GSK Investigational Site, Neuötting

85006

GSK Investigational Site, Phoenix

85201

GSK Investigational Site, Mesa

85259

GSK Investigational Site, Scottsdale

85351

GSK Investigational Site, Sun City

85712

GSK Investigational Site, Tucson

89073

GSK Investigational Site, Ulm

89103

GSK Investigational Site, Las Vegas

90033

GSK Investigational Site, Los Angeles

90073

GSK Investigational Site, Los Angeles

90404

GSK Investigational Site, Santa Monica

90762

GSK Investigational Site, Fürth

91343

GSK Investigational Site, Sepuldeva

92660

GSK Investigational Site, Newport Beach

94315

GSK Investigational Site, Straubing

96047

GSK Investigational Site, Bamberg

97070

GSK Investigational Site, Würzburg

107076

GSK Investigational Site, Moscow

111539

GSK Investigational Site, Moscow

117049

GSK Investigational Site, Moscow

119334

GSK Investigational Site, Moscow

125412

GSK Investigational Site, Moscow

127473

GSK Investigational Site, Moscow

193019

GSK Investigational Site, Saint Petersburg

197376

GSK Investigational Site, Saint Petersburg

226003

GSK Investigational Site, Lucknow

500482

GSK Investigational Site, Hyderabad, Andhra Pradesh

620102

GSK Investigational Site, Yekaterinburg

7571831

GSK Investigational Site, Santiago

35294-0021

GSK Investigational Site, Birmingham

50309-1426

GSK Investigational Site, Des Moines

40536-0284

GSK Investigational Site, Lexington

02118

GSK Investigational Site, Boston

02215

GSK Investigational Site, Boston

08818

GSK Investigational Site, Edison

07052

GSK Investigational Site, West Orange

43210-1250

GSK Investigational Site, Columbus

98122-4358

GSK Investigational Site, Seattle

80069-900

GSK Investigational Site, Curitiba

13083-970

GSK Investigational Site, Campinas

Unknown

GSK Investigational Site, Santiago

GSK Investigational Site, New Delhi

09111

GSK Investigational Site, Chemnitz

09557

GSK Investigational Site, Flöha

04105

GSK Investigational Site, Leipzig

01465

GSK Investigational Site, Radeberg

06406

GSK Investigational Site, Bernburg

06118

GSK Investigational Site, Halle

06618

GSK Investigational Site, Naumburg

07743

GSK Investigational Site, Jena

07747

GSK Investigational Site, Jena-Lobeda

00683

GSK Investigational Site, San Germán

00918

GSK Investigational Site, San Juan

00936

GSK Investigational Site, San Juan

110-744

GSK Investigational Site, Seoul

120-752

GSK Investigational Site, Seoul

138-736

GSK Investigational Site, Seoul

139-711

GSK Investigational Site, Seoul

02660

GSK Investigational Site, Kyiv

Sponsors

Lead Sponsor

All Listed Sponsors
lead

GlaxoSmithKline

INDUSTRY

NCT00113165 - Study Evaluating LAMICTAL Extended-Release Therapy Added To Current Seizure Treatments In Patients With Partial Seizures | Biotech Hunter | Biotech Hunter